Pneumonia - Biotech, Pharma and Life Science Channel
PubMed Articles
Temsirolimus controlled metastatic advanced renal cell carcinoma for over 4 years: a case study.
We present a case report of long-term response with temsirolimus in cytokine refractory metastatic renal cell carcinoma (RCC). A 74-year-old Japanese man was diagnosed with advanced RCC in November 20...
During the first decade of the twentieth century, the German bacteriologist Fred Neufeld, later Director of the Robert Koch-Institute in Berlin, first described the differentiation of pneumococci into...
BACKGROUND: High rates of bacterial coinfection in autopsy data from the 2009 H1N1 influenza ("flu") pandemic suggest synergies between flu and pneumococcal disease (PD) during pandemic conditions, an...
Opportunistic infections caused by Pneumocystis jirovecii ( P. jirovecii , pj), Toxoplasma gondii ( T. gondii , tg), and Mycobacterium avium ( M. avium , ma) are the principal causes of morbidity and...
Interstitial lung disease associated with lung cancer treatment.
Interstitial lung disease is one of the most serious side effects caused by lung cancer treatment. Due to the complexity diagnosis and variability of the disease, it is often not diagnosied and treate...
Consequences of pneumonectomy in the early and late phases.
Pneumonectomy can represent the appropriate surgical treatment option in advanced or centrally localized non-small cell lung cancer (NSCLC). A satisfactory oncologic tumor surgery can be reached in th...
Recently, a novel reassortant virus, influenza A(H3N2)v [A(H3N2)v], was identified as the causative pathogen in 307 human cases of influenza in the United States. A(H3N2)v contains the matrix gene fro...
Metabolomics in pneumonia and sepsis: an analysis of the GenIMS cohort study.
PURPOSE: To determine the global metabolomic profile as measured in circulating plasma from surviving and non-surviving patients with community-acquired pneumonia (CAP) and sepsis. METHODS: Random, ou...
Puumala virus (PUUV) is considered a classic Old World etiologic agent of nephropathia epidemica (NE), or hemorrhagic fever with renal syndrome (HFRS). HFRS is considered to be distinct from hantaviru...
On March 29, 2013, the Chinese Center for Disease Control and Prevention completed laboratory confirmation of three human infections with an avian influenza A(H7N9) virus not previously reported in hu...
News Articles
Pfizer takes its shot at a vaccine for evasive superbug
CHICAGO (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the...
FEATURE-Pfizer takes its shot at a vaccine for evasive superbug
CHICAGO, May 23 (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped deve...
Phagenesis Expands Series B Financing to $17 million
Manchester, UK – 22 May 2013 − Phagenesis, the world’s leading company in the treatment of dysphagia, has expanded its Series B financing to $17m. In 2011, Phagenesis announced a...
Residual Gastric Volume and Risk of Ventilator-Associated Pneumonia—Reply
In Reply: Despite the data obtained in our trial, Drs Elke and Heyland state that by continuously monitoring residual gastric volume, clinicians can detect more readily patients with delayed gastric e...
Residual Gastric Volume and Risk of Ventilator-Associated Pneumonia
To the Editor: Dr Reignier and colleagues provided evidence that not measuring residual gastric volume and adjusting enteral nutrition except in the case of vomiting or regurgitation (intervention gro...
Company’s Virtual Conjugate Vaccine Program Shows Promise Liquidia Technologies today announced that its collaborative agreement with PATH, a global health nonprofit organiz...
Pneumonia — Comprehensive overview covers symptoms, causes, treatment of this serious respiratory infection.
CHAPEL HILL, N.C., May 20, 2013 /PRNewswire/ -- Cempra, Inc. (Nasdaq: CEMP), a clinical-stage pharmaceutical company focused on developing differentiated antibiotics to meet critical medical needs in...
Novel mechanism allows Legionella to hide in body
(Medical Xpress)—The feared Legionella pneumophila is responsible for legionellosis, an infectious disease that can lead to pneumonia. To infect humans, this pathogen has developed a complex method...
TaiGen submits nemonoxacin applications in Taiwan, China
TaiGen Biotechnology Co. Ltd. (Taipei, Taiwan) submitted a pair of NDAs in Taiwan and China for oral nemonoxacin to treat community-acquired pneumonia (CAP). The company, which said these are the firs...
Events
None
Companies
Enanta Phatmaceuticals ARE A RESEARCH AND DEVELOPMENT-FOCUSED BIOTECHNOLOGY COMPANY that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs in t...
Phagenesis is developing the first clinically proven treatment for dysphagia, a debilitating and often lethal condition in which the patientâs ability to swallow is damaged....
Genocea Biosciences was founded in 2006 to commercialize key breakthroughs in vaccine discovery and development. The Companyâs proprietary T cell-directed antigen disc...
Phagenesis is developing the first clinically proven treatment for dysphagia, a debilitating and often lethal condition in which the patientâs ability to swallow is damaged....
Curetis AG is a molecular diagnostic company focusing on the development and commercialization of a universal molecular diagnostics solution for easy-to-use, fast and reliable molecular disease test...
Pulmatrix, Inc., is a clinical stage biotechnology company discovering and developing a new class of therapies for the prevention, treatment and control of respiratory...
MiniVax is a New Orleans, LA based company that specializes in the research and development of novel vaccines and therapeutics for the treatment and prevention of opportunistic fu...
Few inventions in science and medicine have had such a profound effect on human health as the discovery and subsequent development of antibiotics. Following their introduction during World War II ma...
Pulmatrix is discovering and developing a new class of therapies --inhaled cationic airway lining modulators (iCALM) âto prevent and treat respiratory infections and acute ex...
MedImmune Incorporated is a biotechnology company headquartered in Gaithersburg, Maryland with three products on themarket and a diverse product development portfolio. MedImmune is focused on using a...
Clinical Trials
Headache is a common symptom, and patients often seek medical attention at emergency departments due to headaches. The aim of the CoHead Study is to find out if it is possible by measurin...
The Effect of Continuous Versus Enteral Pump Feeding in Aspiration in Tube Fed Patients
Background: Tube feeding had been found to be a cause of aspiration pneumonia. Continuous pump feeding at slower rates as compared to bolus feeding may be less associated with aspiration...
Zithromax EV in Community-Acquired Pneumonia (CAP)
The intravenous (IV) regimen containing azithromycin (Zithromax) plus ampicillin-sulbactam is consistent with current guidelines for the treatment of CAP. In fact the International guideli...
Efficacy of Single Versus Double Dose of Oral Amoxicillin for Non-Severe Pneumonia in Children
The World Health Organization’s (WHO) standard case management strategy for reducing acute respiratory infection (ARI) related mortality recommends oral cotrimoxazole and oral amoxicilli...
Study 0019 (NCT00124020) compares the safety and effectiveness of an investigational drug, telavancin, with vancomycin for the treatment of hospital-acquired pneumonia.
Probiotic Enteral Administration in Mechanically Ventilated Patients
The objective of this study is to assess the effects of a daily enteral supplementation with probiotics within a population of critically ill, mechanically ventilated patients. Especially,...
Clinical Indicators of Radiographic Findings in Patients With Suspected Community-Acquired Pneumonia
This was a study involving the emergency department and outpatient clinics of the David Grant United States Air Force (USAF) Medical Center, a tertiary care facility. Patients 18 years of...
Study 0015 (NCT00107952) compares the safety and effectiveness of an investigational drug, telavancin, with vancomycin for the treatment of hospital-acquired pneumonia.
Study of Lung Proteins in Patients With Pneumonia
This study will examine the different types of proteins present in the lungs of patients with pneumonia to explore the causes of different types of the disease. Pneumonia is a condition th...
Antibiotic Treatment Trial Directed Against Chlamydia Pneumonia in Multiple Sclerosis
Multiple sclerosis (MS) is an inflammatory, demyelinating disease which affects the central nervous system (CNS). The etiology of MS is unknown, although the immune system appears to play...
Videos
Pneumonia
If you like this animation, LIKE us on Facebook: http://www.nucleusinc.com/facebook http://www.nucleusinc.com/medical-animations This 3D medical animation fe...
Medical and Biotech [MESH] Definitions
Neisseria Meningitidis, Serogroup Y
Strains of Neisseria meningitidis which, in the United States, causes disease in mostly adults and the elderly. Serogroup Y strains are associated with PNEUMONIA.
Severe Acute Respiratory Syndrome
A viral disorder characterized by high FEVER, dry COUGH, shortness of breath (DYSPNEA) or breathing difficulties, and atypical PNEUMONIA. A virus in the genus CORONAVIRUS is the suspected agent.
Pneumocystis Jirovecii
A species of PNEUMOCYSTIS infecting humans and causing PNEUMOCYSTIS PNEUMONIA. It also occasionally causes extrapulmonary disease in immunocompromised patients. Its former name was Pneumocystis carinii f. sp. hominis.
Mycoplasma Dispar
A species of gram-negative bacteria causing PNEUMONIA, MYCOPLASMA in calves. Mycoplasma dispar also possibly plays a synergistic role with other BACTERIA and VIRUSES to cause other RESPIRATORY TRACT DISEASES in calves.
Mycoplasma Hyopneumoniae
A species of gram-negative bacteria that causes MYCOPLASMA PNEUMONIA OF SWINE. The organism damages the CILIA in the airways of the pig, and thus compromises one of the most effective mechanical barriers against invading pathogens. The resulting weakening of the IMMUNE SYSTEM can encourage secondary infections, leading to porcine respiratory disease complex.
